Radiation Therapy in Prostate Cancer: Defining the Benefit of Hypofractionation.

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	American Journal of Clinical Oncology
Volume	39
DOIs	https://doi.org/10.1097/COC.0000000000000312
State	Published - Aug 2016

Disciplines

@article{304fa94e4e334e92b2d44b83ceb44858,

title = "Radiation Therapy in Prostate Cancer: Defining the Benefit of Hypofractionation.",

author = "Chirag Shah and Rupesh Kotecha and Kevin Stephans and Rahul Tendulkar",

note = "Am J Clin Oncol. 2016 Aug;39(4):327-8. doi: 10.1097/COC.0000000000000312. Editorial",

year = "2016",

month = aug,

doi = "10.1097/COC.0000000000000312",

language = "American English",

volume = "39",

journal = "American Journal of Clinical Oncology",

}

TY - JOUR

T1 - Radiation Therapy in Prostate Cancer: Defining the Benefit of Hypofractionation.

AU - Shah, Chirag

AU - Kotecha, Rupesh

AU - Stephans, Kevin

AU - Tendulkar, Rahul

N1 - Am J Clin Oncol. 2016 Aug;39(4):327-8. doi: 10.1097/COC.0000000000000312. Editorial

PY - 2016/8

Y1 - 2016/8

UR - https://www.ncbi.nlm.nih.gov/pubmed/27322702

U2 - 10.1097/COC.0000000000000312

DO - 10.1097/COC.0000000000000312

M3 - Article

VL - 39

JO - American Journal of Clinical Oncology

JF - American Journal of Clinical Oncology

ER -